Skip to main content
Clinical Trials/NCT01296516
NCT01296516
Completed
Not Applicable

Early Postpartum Treatment of Gestational Diabetes With Weight Loss and Exercise

Pennington Biomedical Research Center1 site in 1 country7 target enrollmentFebruary 2011

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Gestational Diabetes
Sponsor
Pennington Biomedical Research Center
Enrollment
7
Locations
1
Primary Endpoint
Incidence of glucose intolerance
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

The overall objective of this pilot project is to test in 50 women with a history of gestational diabetes mellitus (GDM), the effectiveness and feasibility of an 8 month intensive lifestyle intervention to reduce the rate of metabolic abnormalities within 1 year after delivery.

Detailed Description

The objective is in comparison to a group of women not enrolled in the lifestyle intervention, 8 months of intensive lifestyle intervention aimed at promoting 7% weight loss through increased physical activity and dietary modification in women with a history of GDM will: 1. decrease body weight and 2. reduce the rate of metabolic abnormalities, 12 months after delivery

Registry
clinicaltrials.gov
Start Date
February 2011
End Date
December 2017
Last Updated
4 years ago
Study Type
Interventional
Study Design
Factorial
Sex
Female

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Leanne Redman

Principle Investigator

Pennington Biomedical Research Center

Eligibility Criteria

Inclusion Criteria

  • Women are required to be enrolled (provided written consent for participation) in the COPSS-GDM study and therefore have met the following inclusion criteria:
  • Postpartum Women ≥18 years to 45 years (inclusive) of age who experienced GDM during index pregnancy
  • English-speaking

Exclusion Criteria

  • Exclusion Criteria:
  • Women enrolled in COPSS-GDM will be excluded if they met the following criteria:
  • Medical Exclusion Criteria
  • History or clinical manifestation of any other significant metabolic, hematologic, pulmonary, cardiovascular, gastrointestinal, neurologic, immune, hepatic, renal, urologic disorders, or cancer
  • Regular use of medications for weight control or psychosis
  • Current use of medication to treat diabetes Psychiatric and Behavioral Exclusion Criteria
  • History or clinical manifestation of any eating disorder
  • History of drug or alcohol abuse (up to 14 drinks a week are allowed) within the past two years Other Exclusion Criteria
  • Pregnancy or pregnancy planned during the coming year
  • Unwilling or unable to adhere to the clinical evaluation schedule over the twelve -month study period

Outcomes

Primary Outcomes

Incidence of glucose intolerance

Time Frame: 8 Months

To examine the incidence of glucose abnormalities (impaired fasting glucose, impaired glucose tolerance, type 2 diabetes) and health outcomes (changes in body fat, waist circumference and blood lipids)in women with a history of gestational diabetes, 12 months postpartum.

Secondary Outcomes

  • Weight loss(8 months)

Study Sites (1)

Loading locations...

Similar Trials